Key result
Astragalus polysaccharides protected mitochondrial ultrastructure, reduced apoptosis, and inhibited oxidative stress in high glucose-challenged or SOD2-silenced H9C2 cells.
Why the study?
Does Astragalus polysaccharides treatment reduce oxidative stress and apoptosis in high glucose-challenged or SOD2-silenced H9C2 cells?
Does Astragalus polysaccharides treatment reduce oxidative stress and apoptosis in high glucose-challenged or SOD2-silenced H9C2 cells?
Astragalus polysaccharides demonstrate protective effects against high glucose-induced oxidative stress and apoptosis in H9C2 cardiomyocytes in vitro.
Hypothesis-generating for APS in diabetic cardiomyopathy; leaves open translation from H9C2 cells to clinical use.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2018) studied high glucose-induced oxidative stress. Astragalus polysaccharides (APS) was evaluated on oxidative stress and apoptosis. Astragalus polysaccharides protected mitochondrial ultrastructure, reduced apoptosis, and inhibited oxidative stress in high glucose-challenged or SOD2-silenced H9C2 cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: